XENE R&D Expenses
Xenon Pharmaceuticals Inc · R&D Expenses
XENE R&D Expenses
Latest reported$99.22Mperiod ending
XENE Quarterly R&D Expenses ($2.84M → $99.22M)
Quarterly R&D Expenses
High-resolution chart · PNG
XENE r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 99,224,000 | |
| 88,508,000 | |
| 87,699,000 | |
| 77,054,000 | |
| 74,985,000 | |
| 61,200,000 | |
| 59,472,000 | |
| 56,970,000 | |
| 49,702,000 | |
| 44,250,000 | |
| 41,076,000 | |
| 42,880,000 | |
| 44,040,000 | |
| 39,516,000 | |
| 34,830,000 | |
| 29,431,000 | |
| 22,146,000 | |
| 19,360,000 | |
| 21,887,000 | |
| 18,891,000 | |
| 18,377,000 | |
| 16,308,000 | |
| 14,967,000 | |
| 13,045,000 | |
| 10,720,000 | |
| 11,791,000 | |
| 11,752,000 | |
| 9,751,000 | |
| 8,205,000 | |
| 9,137,000 | |
| 6,406,000 | |
| 6,240,000 | |
| 5,408,000 | |
| 5,580,000 | |
| 6,397,000 | |
| 7,164,000 | |
| 6,109,000 | |
| 5,903,000 | |
| 4,396,000 | |
| 5,965,000 | |
| 5,103,000 | |
| 4,364,000 | |
| 4,263,000 | |
| 3,793,000 | |
| 3,669,000 | |
| 3,427,000 | |
| 3,453,000 | |
| 3,216,000 | |
| 2,566,000 | |
| 2,533,000 | |
| 2,743,000 | |
| 2,577,000 | |
| 3,491,500 | |
| 3,491,500 | |
| 2,842,500 | |
| 2,842,500 |